These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 30353201)

  • 1. Efficacy of oral trazodone slow release following intravenous administration in depressed patients: a naturalistic study.
    Fiorentini A; Rovera C; Caldiroli A; Arici C; Prunas C; Di Pace C; Paletta S; Pozzoli SM; Buoli M; Altamura AC
    Riv Psichiatr; 2018; 53(5):261-266. PubMed ID: 30353201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy and tolerability of once-daily controlled-release trazodone for depressed mood, anxiety, insomnia, and suicidality in major depressive disorder.
    Sheehan DV; Rozova A; Gossen ER; Gibertini M
    Psychopharmacol Bull; 2009; 42(4):5-22. PubMed ID: 20581790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative, randomized, double-blind study of trazodone prolonged-release and sertraline in the treatment of major depressive disorder.
    Munizza C; Olivieri L; Di Loreto G; Dionisio P
    Curr Med Res Opin; 2006 Sep; 22(9):1703-13. PubMed ID: 16968574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is trazodone more effective than clomipramine in major depressed outpatients? A single-blind study with intravenous and oral administration.
    Buoli M; Rovera C; Pozzoli SM; Fiorentini A; Cremaschi L; Caldiroli A; Altamura AC
    CNS Spectr; 2019 Apr; 24(2):258-264. PubMed ID: 29081313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of prolonged-release trazodone in major depressive disorder: a multicenter, randomized, double-blind, flexible-dose trial.
    Zhang L; Xie WW; Li LH; Zhang HG; Wang G; Chen DC; Cao Y; Cui LJ; Zhang KR; Shi JG; Tan QR; Zheng HB; Xu XF; Cheng ZH; Zhao JP
    Pharmacology; 2014; 94(5-6):199-206. PubMed ID: 25376160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Once-a-Day Trazodone in the Treatment of Depression in Routine Clinical Practice.
    Češková E; Šedová M; Kellnerová R; Starobová O
    Pharmacology; 2018; 102(3-4):206-212. PubMed ID: 30099450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Trazodone Contramid® in clinical practice: personalizing antidepressant intervention].
    Fagiolini A; Amodeo G; Goracci A; Blardi P
    Riv Psichiatr; 2016; 51(4):123-128. PubMed ID: 27727261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of trazodone and fluoxetine in the treatment of major depression: therapeutic pharmacokinetic and pharmacodynamic interactions through formation of meta-chlorophenylpiperazine.
    Maes M; Westenberg H; Vandoolaeghe E; Demedts P; Wauters A; Neels H; Meltzer HY
    J Clin Psychopharmacol; 1997 Oct; 17(5):358-64. PubMed ID: 9315986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Confirmation of the neurophysiologically predicted therapeutic effects of trazodone on its target symptoms depression, anxiety and insomnia by postmarketing clinical studies with a controlled-release formulation in depressed outpatients.
    Saletu-Zyhlarz GM; Anderer P; Arnold O; Saletu B
    Neuropsychobiology; 2003; 48(4):194-208. PubMed ID: 14673218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rediscovering trazodone for the treatment of major depressive disorder.
    Fagiolini A; Comandini A; Catena Dell'Osso M; Kasper S
    CNS Drugs; 2012 Dec; 26(12):1033-49. PubMed ID: 23192413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extended-release trazodone (Oleptro) for depression.
    Med Lett Drugs Ther; 2010 Nov; 52(1351):91-2. PubMed ID: 21068704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week study.
    Hu YD; Xiang YT; Fang JX; Zu S; Sha S; Shi H; Ungvari GS; Correll CU; Chiu HF; Xue Y; Tian TF; Wu AS; Ma X; Wang G
    Psychol Med; 2016 Feb; 46(3):623-35. PubMed ID: 26478208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of trazodone in a single dose before bedtime for sleep disorders accompanied by a depressive state: dose-finding study with no concomitant use of hypnotic agent.
    Mashiko H; Niwa S; Kumashiro H; Kaneko Y; Suzuki S; Numata Y; Horikoshi R; Watanabe Y
    Psychiatry Clin Neurosci; 1999 Apr; 53(2):193-4. PubMed ID: 10459686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose-trazodone-induced disorganized type psychosis.
    Mizoguchi Y; Monji A
    J Neuropsychiatry Clin Neurosci; 2005; 17(2):253-4. PubMed ID: 15939985
    [No Abstract]   [Full Text] [Related]  

  • 15. Safety, tolerability, and pharmacokinetics of once-daily trazodone extended-release caplets in healthy subjects.
    Karhu D; Gossen ER; Mostert A; Cronjé T; Fradette C
    Int J Clin Pharmacol Ther; 2011 Dec; 49(12):730-43. PubMed ID: 22122815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability of mirtazapine in treating major depressive disorder with anxiety symptoms: an 8-week open-label randomised paroxetine-controlled trial.
    Kim JE; Yoon SJ; Kim J; Jung JY; Jeong HS; Cho HB; Shin E; Lyoo IK; Kim TS
    Int J Clin Pract; 2011 Mar; 65(3):323-9. PubMed ID: 21314870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A lasting change in trazodone response after non-convulsive electroshock therapy for medication-resistant senile depression.
    Shen H; Awata S; Konno M; Sato M
    Psychiatry Clin Neurosci; 1998 Feb; 52(1):111-3. PubMed ID: 9682943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TED-trazodone effectiveness in depression: a naturalistic study of the effeciveness of trazodone in extended release formulation compared to SSRIs in patients with a major depressive disorder.
    Dudek D; Chrobak AA; Krupa AJ; Gorostowicz A; Gerlich A; Juryk A; Siwek M
    Front Pharmacol; 2023; 14():1296639. PubMed ID: 38027034
    [No Abstract]   [Full Text] [Related]  

  • 19. A randomized, double-blinded, placebo-controlled study to evaluate the efficacy and safety of venlafaxine extended release and a long-term extension study for patients with major depressive disorder in Japan.
    Higuchi T; Kamijima K; Nakagome K; Itamura R; Asami Y; Kuribayashi K; Imaeda T
    Int Clin Psychopharmacol; 2016 Jan; 31(1):8-19. PubMed ID: 26513202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute dystonic reaction with trazodone.
    Tesler-Mabe CS
    Can J Psychiatry; 1998 Dec; 43(10):1053. PubMed ID: 9868576
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.